Eden Medical News
At Eden Medical we have been developing a number of innovative technologies for the wound care marketplace. Check out of some of the most our most recent publications and videos.
Infrared Eyes (iREyes)- We have published a informative poster paper showing how thermal imaging can predict wound healing by a wound healing index and assess ulcer recurrence to provide ulcer-free days. It was published at the International Diabetic Foot Conference (DFCon) in 2019, "Thermal Indexing to Quantify Wound Healing".
See More info.
World's First Disposable Medical Pump-EdenPump
The EdenPump (US Patent 9,046,085) is a body worn medical pump(16 mm diameter) which operates using a polymer muscle. It's applications include wound irrigation, subcutaneous injection, and wound therapy. It has been clinically proven for medical sealant delivery for a skin barrier product.
See More Info- in-house bench-test video(dispensing medical grade sealant)
Wound Ulcer Risk Assessment Tool
The Foot Infrared Rolling Scan Transducer applies "mechno-transduction" to apply stress to tissue to determine ulceration risk. A regional perfusion index (RPI) is generated by near-infrared light as a hand-held mobile device. See more info for our recently issues US utility patent.
Commercialization Accelerator Program(CAP) Grant
Eden Medical was recently selected for 2019-2020 Commercialization Accelerator Program (CAP) by the National Institutes of Health (NIH) SBIR (Small Business Innovation Research) program office. This award is following our $1.5 M Phase 2 SBIR funded grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the development of the Infrared Eyes (iREyes) imaging system. The selection for this program highlights the commercial value and clinical significance for Artificial Intelligence (AI) guided thermal imaging and its potential to assess ulcer recurrence and provide ulcer-free days. This highly competitive CAP NIH program will help us strengthen our commercialization plan and business model, and engage with both industry partners and investors.